Guided Meditation During Radiation Therapy for Brain Tumors
Launched by UNIVERSITY OF UTAH · Dec 8, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how guided meditation can help reduce anxiety in patients receiving radiation therapy for brain tumors. The researchers want to find out if listening to a 5-minute mindfulness audio recording during each radiation session can make patients feel less anxious compared to those who do not receive this intervention.
To participate in the trial, individuals must be at least 18 years old, have a confirmed brain tumor, and be eligible for 25 to 33 sessions of radiation treatment. They should be able to understand and provide consent for the study. Participants will be randomly assigned to either the guided meditation group or the standard care group, which means they may or may not receive the meditation practice. The study is currently recruiting participants and welcomes individuals of all genders. If you or a loved one are interested in how mindfulness might support your treatment, this trial could be an important opportunity to consider.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant aged ≥ 18 years.
- • Radiologically confirmed tumor of the brain. Note: Participants may have tumor resected after diagnosis.
- • Eligible to undergo radiation treatment for brain tumor for 25-33 treatments.
- • Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment.
- • Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2.
- • MoCA mini score ≥ 11
- • Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.
- Exclusion Criteria:
- • Active suicidal ideation or active psychotic state in the opinion of the investigator.
- • An unstable illness that, in the opinion of the investigator, would interfere with study treatment.
- • Prior radiation therapy to the brain.
- • Inability to understand and/or speak the English language.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Lindsay Burt, MD
Principal Investigator
Huntsman Cancer Institute/ University of Utah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported